4D Molecular Therapeutics, Inc. (FDMT): Why Are Analysts Bullish On This Shorted Stock?

4D Molecular Therapeutics, Inc. (FDMT): Why Are Analysts Bullish On This Shorted Stock?

The article discusses the controversy surrounding short selling in the stock market and highlights 4D Molecular Therapeutics, Inc. as a biotech company with promising treatments. Despite being one of the most shorted stocks, analysts have a positive outlook on its future growth potential.

Read More

Did you find this insightful?